Biguanides Market Size, Share & Trends Analysis Report, By Type (Metformin, Phenformin), By Distribution Channel (Hospitals, Retail Pharmacies, and Others) and By Region, And Segment Forecasts, Till : 2030

Report ID : AMR1004984 | Industries : Healthcare | Published On :January 2024 | Page Count : 210

Biguanides Market Size, Share & Trends Analysis Report, By Type (Metformin, Phenformin), By Distribution Channel (Hospitals, Retail Pharmacies, and Others) and By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Analytical Market Research, the global Biguanides market estimated at USD 5.1 billion in 2022 and will expand at a compound annual growth rate (CAGR) of 4% from 2023 to 2030. Key players in the Biguanides market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic Biguanides market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

Biguanides MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Growing Demand in Water Treatment Applications
One significant driver for the Biguanides market is the increasing demand for these chemicals in water treatment applications. Biguanides are known for their effectiveness in controlling microbial growth in swimming pools, spas, and industrial water systems. As concerns about water quality and safety rise, the demand for efficient water treatment solutions, including Biguanides, continues to grow.
Regulatory Challenges and Environmental Concerns
A key restraint for the Biguanides market is the presence of regulatory challenges and environmental concerns associated with their usage. Regulatory authorities may impose restrictions on certain Biguanide formulations due to potential environmental impact or health concerns. Stricter regulations and the need for eco-friendly alternatives pose challenges for the growth of the Biguanides market. Companies in the industry must navigate these regulatory landscapes and invest in sustainable practices to address environmental concerns.

How are Segments Performing in the Global Biguanides Market?

Biguanides Type Segment Breakdown
According to Analytical Market Research, the Biguanides market by Type is segmented into Metformin, Phenformin.
Biguanides Distribution Channel Segment Breakdown
According to Analytical Market Research, based on vehicle type, the market is segmented into Hospitals, Retail Pharmacies, and Others.
Biguanides Geographic Exploration
According to Analytical Market Research, the North America region is predicted to dominate the market, owing to the rise in the automotive industry in the region. Other regions competing in the market are North America, Europe, Middle East and Africa and Latin America respectively.

COMPETITIVE LANDSCAPE & RECENT DEVELOPMENT: Biguanides

The significant players rapidly evolve with new strategies to attain a competitive edge and capture significant market share.
• For Instance, in August 2022, Akums Drugs & Pharmaceuticals Limited has released new diabetes treatments: Vildagliptin SR and Metformin SR pills. This allows diabetic patients to maintain adequate glycemic control. It aids the patient in avoiding hypoglycemia and weight gain during pharmaceutical use.

Noticeable Players Functioning in The Global Biguanides Market Include:

• Sanofi-Aventis
• Takeda Pharmaceuticals
• Eli Lilly
• Oramed Pharmaceuticals
• Boehringer Ingelheim
• Merck & Co. Inc.
• Novo Nordisk
• Bristol-Myers Squibb
• Halozyme Therapeutics
• Pfizer.

KEY BREAKDOWN: Biguanides Market

By Type:
• Metformin
• Phenformin
By Distribution Channel
• Hospitals
• Retail Pharmacies
• Others

Geographical Exploration:

• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o South East Asia
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of Latin America
• Middle East and Africa
o GCC Countries
o South Africa
o Rest of MEA

1. Research Methodology
1.1. Global Biguanides Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data Sources
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Biguanides Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Distribution Channels
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Biguanides Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Biguanides Market Outlook: Type
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Type, 2023 – 2030
4.3.2.1. Metformin
4.3.2.2. Phenformin
4.4. Global Biguanides Market Outlook: Distribution Channel
4.4.1. Introduction / Key Findings
4.4.2. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
4.4.2.1. Hospitals
4.4.2.2. Retail Pharmacies
4.4.2.3. Others
5. Global Biguanides Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Biguanides Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Type
6.3.3. By Distribution Channel
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
6.5.1. Allergic Biguanides
6.5.2. Bacterial Biguanides
6.5.3. Viral Biguanides
6.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
6.6.1. Ointment
6.6.2. Drops
6.6.3. Drugs
7. Europe Biguanides Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Type
7.3.3. By Distribution Channel
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
7.5.1. Allergic Biguanides
7.5.2. Bacterial Biguanides
7.5.3. Viral Biguanides
7.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
7.6.1. Ointment
7.6.2. Drops
7.6.3. Drugs
8. Asia Pacific Biguanides Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Type
8.3.3. By Distribution Channel
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
8.5.1. Allergic Biguanides
8.5.2. Bacterial Biguanides
8.5.3. Viral Biguanides
8.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
8.6.1. Ointment
8.6.2. Drops
8.6.3. Drugs
9. Latin America Biguanides Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Type
9.3.3. By Distribution Channel
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
9.5.1. Allergic Biguanides
9.5.2. Bacterial Biguanides
9.5.3. Viral Biguanides
9.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
9.6.1. Ointment
9.6.2. Drops
9.6.3. Drugs
10. Middle East & Africa Biguanides Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Type
10.3.3. By Distribution Channel
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
10.5.1. Allergic Biguanides
10.5.2. Bacterial Biguanides
10.5.3. Viral Biguanides
10.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
10.6.1. Ointment
10.6.2. Drops
10.6.3. Drugs
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. Pfizer.
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. Sanofi-Aventis
11.3.3. Takeda Pharmaceuticals
11.3.4. Eli Lilly
11.3.5. Oramed Pharmaceuticals
11.3.6. Boehringer Ingelheim
11.3.7. Merck & Co. Inc.
11.3.8. Novo Nordisk
11.3.9. Bristol-Myers Squibb
11.3.10. Halozyme Therapeutics